News

Date
Title
  1. 01/18/2017 Catalent to Discuss Accelerated Biopharmaceutical Development at WCBP Conference

  2. 01/09/2017 Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates

  3. 12/15/2016 Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative

  4. 12/08/2016 Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative

  5. 12/06/2016 Dr. Joseph Reo Appointed as Catalent’s Director of Global Scientific Affairs

  6. 11/29/2016 Catalent to Present at Upcoming Industry Conference

  7. 11/28/2016 Catalent to Acquire Accucaps Expanding Softgel Development & Manufacturing

  8. 11/23/2016 Catalent Celebrates 20 Years at Bolton Facility

  9. 11/17/2016 Catalent Appoints Shannon Trilli in New Role for Corporate Responsibility

  10. 11/11/2016 Catalent Expert to Discuss Evolving and Innovative Logistical Strategies

  11. 11/08/2016 Catalent Experts Present at AAPS Annual Convention

  12. 11/04/2016 Expert Panel To Discuss Integrated Approach To Strategic Drug Development

  13. 10/24/2016 Catalent Celebrates Ground Breaking For Expanded Biologics Facility

  14. 10/20/2016 Catalent Appoints Kunal Jaiswal to VP, Strategic Development for Clinical Supply

  15. 10/19/2016 Catalent Presents Innovative Softgel Developments at OTC Conference in Singapore

  16. 10/18/2016 Catalent To Provide Fill & Finish Services For Commercial Supply

  17. 10/13/2016 Catalent Biologics Announces Agreement With Moderna Therapeutics

  18. 10/05/2016 Catalent Wins Prestigious CPhI Pharma Award at CPhI Worldwide

  19. 10/04/2016 Catalent Biologics & Triphase Accelerator Corporation Announce License Agreement

  20. 09/27/2016 Catalent Showcases Advanced Technologies & Solutions at CPhI Worldwide

  21. 09/21/2016 Catalent Biologics Appoints Director of R&D, Bioanalytical Chemistry

  22. 09/13/2016 Catalent Signed Agreement to Acquire Pharmatek Laboratories

  23. 08/30/2016 Catalent Executives Invited to Speak at Upcoming Conferences

  24. 08/02/2016 Catalent Biologics Collaborates to Develop New & More Efficacious Antibodies

  25. 07/13/2016 Catalent to Present at CRS on Early-Stage Dose Form Optimization & More

  26. 07/05/2016 Catalent Announces Appointment of New General Manager of Australia Facility

  27. 06/30/2016 Catalent Agreement to Commercially Supply Palatin Technologies’ New Product

  28. 06/29/2016 Catalent to Present at Medicinal Chemistry Ireland Conference

  29. 06/27/2016 Catalent Launches FastChain™ Demand Led Clinical Supply Solution

  30. 06/23/2016 Catalent to Discuss Clinical Supply Chain Solutions at DIA 2016 Conference

  31. 06/21/2016 OPKO’s Rayaldee® Product Uses Catalent’s OptiShell™ Technology

  32. 06/07/2016 Catalent Expert To Present On Global Cold Chain Clinical Supply Strategies

  33. 06/06/2016 Catalent Opens New Clinical Supply Facility on its Japan Campus

  34. 06/02/2016 Launch of New Platform for Accelerated Development of Biological Drug Molecules

  35. 05/26/2016 Catalent Strengthens Leadership Position in Asia-Pacific

  36. 05/19/2016 Catalent Introduces New Label to Improve Storage & Retrieval of Patient Kits

  37. 04/26/2016 Catalent Wins Prestigious ‘Editor’s Choice’ Award At Interphex

  38. 04/21/2016 Catalent Experts At Upcoming PEGS Conference in Boston

  39. 04/19/2016 Catalent Experts to Discuss Innovative Delivery Technologies at Interphex

  40. 04/15/2016 Catalent to Present at CPhI Japan Conference

  41. 04/13/2016 Catalent Institute Experts to Present at Respiratory Drug Delivery

  42. 04/11/2016 Catalent Executives to Present at Upcoming Asian ISPE Conferences

  43. 03/17/2016 Catalent to Present at Biopharma Asia in Singapore

  44. 03/15/2016 Advances in Biologic Development & Delivery Symposium by Catalent Institute

  45. 03/10/2016 Catalent Biologics to Present at BioProcess International West Conference

  46. 03/07/2016 Catalent Presents Strategies for Integrating Global Cold Chain Supply Networks

  47. 03/02/2016 Catalent To Speak On Patient Perceptions & Clinical Trial Supply Models

  48. 03/01/2016 Acticor Biotech selects GPEx® Technology to develop ACT-017

  49. 02/02/2016 Catalent Invests $4.6M To Further Expand Clinical Trials Hub In Singapore

  50. 02/01/2016 Catalent Presents at IPEC-Europe Conference

  51. 01/28/2016 Catalent & Cerenis Therapeutics Announce Phase III Trial of CER-001

  52. 01/26/2016 Catalent Presents "Overcoming Challenges In Formulation Development" at Informex

  53. 01/21/2016 Catalent Announces Appointment of New Development & Analytical Services VP

  54. 01/19/2016 Catalent to Open New Clinical Supply Facility in Japan

  55. 01/14/2016 Evolving to a More Efficient and Lean Clinical Trial Supply Model

  56. 01/13/2016 Catalent Biologics Collaborates with Roche on SMARTag™ Technology

  57. 12/09/2015 Catalent Biologics Announces Appointment of VP, Business Development & Licensing

  58. 12/07/2015 Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent

  59. 11/26/2015 Catalent Institute Announces Educational Workshop Series

  60. 11/25/2015 Catalent to Discuss Challenges & Logistics of Clinical Trials in Asia

  61. 11/20/2015 Catalent Biologics Expands Analytical And Process Development Capabilities

  62. 11/16/2015 Catalent Working to Re-Start Production at French Facility

  63. 10/27/2015 Catalent Quadruples Cold Chain Capacity in Shanghai

  64. 10/21/2015 Catalent Announces New President of Clinical Supply Services Business

  65. 10/14/2015 Catalent Wins ‘Innovation In Process & Formulation Development’ Award at CPhI

  66. 10/13/2015 Catalent Announces Appointment Of Vice President Of Science And Technology

  67. 10/01/2015 Catalent Launches Optiform® Solution Suite For Accelerated Drug Development

  68. 09/28/2015 Catalent Quality Expert Invited To Discuss Effective Auditing Strategies

  69. 09/24/2015 Demand Led Supply Model To Improve Clinical Trial Supply Chains

  70. 09/10/2015 Patient-Centric Drug Design & Innovative Technologies Symposium

  71. 08/27/2015 Clinical Trial Supply Chain Logistics Discussed At Upcoming Flypharma Conference

  72. 08/05/2015 Catalent Biologics Announces New Advisory Board

  73. 08/03/2015 OptiShell™ Technology for New Chronic Kidney Disease Treatment

  74. 07/28/2015 Catalent, Inc. Appoints J. Martin Carroll to its Board of Directors

  75. 07/23/2015 Applied Drug Delivery Institute Recognizes Innovators with Global Award

  76. 07/22/2015 Catalent Announces Busy Agenda At Controlled Release Society Annual Meeting

  77. 07/07/2015 Catalent Biologics Adds New Technology Platform

  78. 07/02/2015 Catalent Makes Two Key European Appointments In Oral Dose Manufacturing

  79. 06/16/2015 Catalent Expands Packaging Capabilities In Singapore

  80. 05/15/2015 Lipid-Based Solutions to Improve Bioavailability at Drug Delivery Congress

  81. 04/21/2015 Expansion of Glass-Free Injectable Platform with New ADVASEPT™ Lock Technology

  82. 04/20/2015 Catalent Awarded Grant As Part Of Vaccine Research Consortium

  83. 04/15/2015 Catalent Completes Expansion of Complex Oral Solid Manufacturing Facility

  84. 04/14/2015 Catalent To Launch Extension To ADVASEPT™ Technology Range At Interphex

  85. 04/09/2015 Enhanced Solubility and Speed to Market Discussed by Catalent Expert at DDF

  86. 03/30/2015 Catalent Acquires Pharmapak, Australia

  87. 03/20/2015 Catalent to Present Use Of New Technologies At Upcoming Bioassay Conference

  88. 03/16/2015 Catalent Announces New Organization To Speed New Products To Market

  89. 02/26/2015 Catalent Expands Capabilities within European Clinical Supply Services Network

  90. 02/18/2015 Catalent to Present New Data on Benefits of SMARTag™ Technology at World ADC

  91. 02/05/2015 Lipid-Based Solutions Workshop Presented At Drug Delivery & Formulation Summit

  92. 02/02/2015 Catalent to Present Bioavailabity Solutions & Drug Delivery Toolkit at InformEx

  93. 01/28/2015 Catalent Pharma Solutions Further Expands Its High Potency Handling Capability

  94. 01/23/2015 Catalent VP Of Global Operations Wins Program Director Of The Year Award

  95. 01/22/2015 Catalent Expands Coating & Packaging Operations In Eberbach, Germany

  96. 01/19/2015 Catalent Biologics & MGC Pharma Announce Partnership: Biomanufacturing In Asia

  97. 01/14/2015 Catalent & Sanofi To Collaborate On SMARTag™ Antibody-Drug Conjugate Technology

  98. 01/07/2015 Catalent Appoints Two Industry Leaders To Its European Clinical Supply Network

  99. 12/04/2014 Catalent & SELLAS Sign Exclusive Agreement For Therapeutic Reprofiling

  100. 12/02/2014 Catalent and Valerion Collaborate on New Treatments For Orphan Genetic Disorders

  101. 11/13/2014 Catalent Acquires Micron Technologies

  102. 11/03/2014 Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities

  103. 10/30/2014 Latest Developments in Bioavailability, Drug Delivery & More Presented At AAPS

  104. 10/28/2014 Catalent Appoints Mark Bisset as President, Catalent Asia Pacific

  105. 10/21/2014 ADC Generation Using SMARTag™ Technology Presented At World ADC Congress

  106. 10/14/2014 Catalent Appoints Senior Vice President And General Counsel

  107. 10/08/2014 Catalent and Redwood Bioscience Win Inaugural ‘Innovation In Partnering’ Award

  108. 10/06/2014 Catalent Applied Drug Delivery Institute Collaborates With Lung Cancer Alliance

  109. 10/02/2014 Catalent Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform

  110. 09/30/2014 Catalent Announced Full Agenda for 25th Annual CPhI Worldwide Conference

  111. 09/25/2014 Catalent Announces Two Senior Executive Appointments to Its Development Business

  112. 09/24/2014 Catalent and Cingulate Therapeutics Sign Exclusive Agreement

  113. 09/17/2014 New OptiPact™ Technology Introduced By Catalent

  114. 09/15/2014 Best Practices In Risk Mitigation Presented By Catalent At Internal Audit Summit

  115. 09/08/2014 Bioavailability Symposium Announced by Catalent Applied Drug Delivery Institute

  116. 09/04/2014 Catalent Announces Two Senior Appointments To Its Biologics Business

  117. 08/27/2014 Catalent & Minomic Collaborate To Bring New Prostate Cancer Treatment To Market

  118. 08/14/2014 Catalent Confirms Appointment of Two Healthcare Executives to Board of Directors

  119. 07/31/2014 Catalent, Inc. Announces Pricing of Its Initial Public Offering

  120. 07/29/2014 Catalent Expert to Present at Japan Society of Drug Delivery Systems

  121. 07/09/2014 Nine Catalent Experts to Present on Industry Challenges & Drug Delivery at CRS

  122. 07/01/2014 Catalent Marks 40 Years in Japan with New Investments and Country Leader

  123. 06/26/2014 FDA Invites Catalent to Present on New Drug Delivery Technologies

  124. 06/24/2014 New Study: Decreased Mortality & Better Tolerability of ADC w/ SMARTag Platform

  125. 06/19/2014 Latest Developments in ADC Presented by Catalent and Redwood Biosciences at BIO

  126. 06/16/2014 Creating A Culture of Operational Excellence Presented at European Summit

  127. 06/11/2014 Annual Competition Recognizes Talent In Graduate Pharmaceutical Programs

  128. 05/07/2014 Innovation Symposium Announced By Catalent Applied Drug Delivery Institute

  129. 05/02/2014 Oral Drug Delivery Formulation Techniques Showcased At Recent Event

  130. 04/30/2014 Continual Performance Monitoring Of Potency Assays Presented At IBC Conference

  131. 04/03/2014 Catalent Agrees To Biosimilar Collaboration With Zhejiang Hisun Pharma

  132. 04/02/2014 New Drug Delivery Technologies to be Presented by Catalent Experts at ICSE Japan

  133. 03/24/2014 Catalent Increases Stake In Redwood Bioscience

  134. 03/17/2014 Catalent Celebrates 80 Years of Softgel Innovation at Interphex

  135. 03/11/2014 Catalent Launches ADVASEPTTM For Glass-Free Delivery Of Injectable Drugs

  136. 03/10/2014 Use Of QbD To Mitigate Risk In Aseptic Fill/Finish Presented At PDA Conf

  137. 03/06/2014 Catalent Announces Agreement For One Of The First Regenerative Therapies

  138. 02/26/2014 Catalent Announces Two Senior Appointments To Expand Biologics Business

  139. 02/17/2014 Catalent and Redwood Bioscience to Present on Next Generation Drug Conjugates

  140. 02/10/2014 Improved Drug Delivery in Animal Health Presented by Catalent Experts

  141. 02/06/2014 Leading Industry & Academic Experts to Discuss Drug Delivery Technologies

  142. 02/04/2014 Catalent Demonstrates Process Excellence During PEX Week

  143. 01/24/2014 Catalent Files Registration Statement For Initial Public Offering

  144. 01/24/2014 New Technologies and QbD Concepts to be Discussed at Forthcoming Events

  145. 01/23/2014 3rd Annual Global Academic Competition for Life Science Leaders of Tommorrow

  146. 01/07/2014 Catalent and Adamas Pharmaceuticals Enter Into Phase III Manufacturing Agreement

  147. 12/09/2013 Orphan Drug Model to be Debated by Catalent Expert at FDA/CMS Summit

  148. 12/08/2013 Extractables and Leachables for Parenteral and Opthalmic

  149. 12/05/2013 Catalent & Redwood Bioscience present Next Generation Antibody Drug Conjugates

  150. 11/20/2013 Pharmacyclics and Catalent Solidify Partnership on Imbruvica™

  151. 11/19/2013 Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal

  152. 11/11/2013 Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business

  153. 11/06/2013 New Interactive Web Tool Helps Innovators

  154. 11/04/2013 New Drug Delivery Technologies Presented at AAPS

  155. 10/16/2013 Catalent Presents New Technologies at CPhI

  156. 10/14/2013 Compelling New Data on Next Generation Antibody Drug Conjugates

  157. 10/08/2013 Catalent Acquires Relthy to Expand South American Softgel Business

  158. 09/25/2013 Catalent Announces Expansion of Optimelt™ Hot Melt Extrusion

  159. 09/22/2013 Catalent Participates in Inaugural Blackstone Veterans Hiring Summit

  160. 09/19/2013 The Institute Appoints Professor Claus-Michael Lehr to Advisory Board

  161. 09/16/2013 Catalent Pharma Solutions and Supernus Partner for Supply of Trokendi XR™

  162. 09/11/2013 Catalent Experts to Present Collaborative Product Development at EPTM

  163. 09/08/2013 Catalent Appoints First President of Asia Pacific

  164. 09/03/2013 Catalent Applied Drug Delivery Institute Announces European Educational Event

  165. 07/28/2013 Catalent Completes Acquisition of Majority Share in Chinese Softgel Business

  166. 07/15/2013 Advances in Modified & Controlled Release - Catalent at 40th Annual CRS Meeting

  167. 07/09/2013 Catalent and Biota Pharmaceuticals Expand Their Alliance

  168. 07/07/2013 Catalent Creates New Advanced Delivery Technologies Business Unit

  169. 06/19/2013 Catalent Officially Launches New Capabilities at CPhI China

  170. 06/11/2013 Catalent Breaks Ground of its Winchester, KY CR Manufacturing Facility

  171. 05/15/2013 Worldwide Competition Recognizes Next-Generation Scientific Talent

  172. 05/12/2013 Catalent Wins Two Prestigious Process Excellence Awards

  173. 05/09/2013 Omega-3 Trends and Innovations at Vitafoods

  174. 04/24/2013 Catalent Announces Opening of New Single-Use Biomanufacturing Center

  175. 04/22/2013 Company Receives Two PEX Network European Awards Nominations

  176. 04/18/2013 Catalent Experts Exhibit and Present at BIO and Interphex 2013

  177. 04/15/2013 Catalent Announces Two Senior Appointments to Drive Growth in China

  178. 04/09/2013 Catalent Biologics Expands Into ADCs Through Exclusive License

  179. 03/25/2013 catalent leader to chair discussions on optimizing clinical operation in china

  180. 03/19/2013 Catalent Australia and Medipharm Partner to Supply Malaysian Market

  181. 03/18/2013 Experts Consider Challenging Tech Transfers at Dusseldorf Pharma Congress

  182. 03/10/2013 Catalent Announces Major China Expansion with Two New Facilities

  183. 03/06/2013 Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader

  184. 03/04/2013 Catalent Quality Development Leader to Present at China Clinical Trials

  185. 02/25/2013 Speeding Drug Development Through Use of High Yield Stable GPEx® Technology

  186. 02/24/2013 Catalent Presents Drug Delivery Strategies at Improving Solubility in Philly

  187. 01/29/2013 Catalent Applied Drug Delivery Institute Holds 2nd Global Academic Competition

  188. 01/28/2013 The Impact of Emerging Bioassay Technologies Presented at WCBP Conference

  189. 01/22/2013 Presenting Better Treatments Through Bioavailability Enhancement

  190. 01/21/2013 Accelerating Development from CDNA Sequence to Master Cell Bank Candidate

  191. 01/09/2013 Catalent Makes Investment to Expand Inhalation Capabilities in RTP, NC

  192. 01/07/2013 Catalent and Aegerion Partner on Launch of Newly FDA Approved Juxtapid™

  193. 12/12/2012 Catalent and UMN Pharma announce collaboration for production in Japan

  194. 12/12/2012 Bio-Process Systems Alliance Elects New Director from Catalent

  195. 12/06/2012 Catalent to supply the newly approved Exelixis COMETRIQ™

  196. 11/27/2012 Oral Drug Delivery for Macromolecules Using Softgel Lipid Delivery System

  197. 11/25/2012 Faster Pipeline Progression Discussed by Catalent Expert EAC 2012

  198. 11/19/2012 Catalent Experts to Speak at Pharma Integrates 2012

  199. 11/12/2012 Catalent Announces Cell Line Sales Agreement with CEVEC Pharmaceuticals

  200. 11/08/2012 Extractable and Leachables for Biological and High Risk Dosage Forms

  201. 10/16/2012 Catalent Wins Fifth Consecutive European Outsourcing Award

  202. 10/15/2012 Catalent Announces Launch of Catalent Applied Drug Delivery Institute

  203. 10/09/2012 Catalent Licenses Technology with NJIT

  204. 10/07/2012 Catalent Present at the 2012 AAPS Annual Meeting

  205. 10/01/2012 Catalent Announces Global Alliance with PAREXEL

  206. 09/30/2012 Catalent Enters Into Commerical Supply Agreement with Vivus

  207. 09/19/2012 Catalent Expert Invited to Speak on Advanced Delivery Technologies

  208. 09/17/2012 Optimizing Clinical Supply Processes and Maximizing Budgets Presented

  209. 09/17/2012 Catalent Completes $350 Million 7.875% Senior Notes Offering

  210. 09/12/2012 Catalent and CTC Partner to Help Korean Pharma

  211. 09/05/2012 Catalent Quality Expert Presents At 2012 ICH Q10 Workshop

  212. 07/23/2012 Catalent Announces Commencement of Supply of Abilify®

  213. 07/18/2012 Expert Invited to Speak on the Advantages of Single Use Biomanufacturing

  214. 07/17/2012 Catalent Expert Will Present at PERI

  215. 07/10/2012 Catalent Expert Presents at 2012 CRS Conference

  216. 06/21/2012 Catalent Experts Present at CPhI/ICSE China 2012

  217. 06/20/2012 Catalent and Bend Provide Solutions for Controlled-Release Technologies

  218. 06/19/2012 Frazier Healthcare Acquires Packaging Operations from Catalent Pharma Solutions

  219. 06/10/2012 Catalent Expert Conducts Workshop On Solid Dosage Forms

  220. 06/04/2012 Catalent Increases Sterile Fill-Finish Manufacturing Capacity

  221. 05/29/2012 Catalent Enters Agreement to Sell Its U.S. Commercial Packaging Operations

  222. 05/15/2012 Catalent Announces Winners of Global Academic Competion

  223. 05/13/2012 Drug Delivery/Formulation Issues Identified As Concerns In Technology Survey

  224. 05/10/2012 Catalent Expert Gives Working Group Update At Conference

  225. 04/29/2012 Biosimilars Webinar Presented by Catalent Expert

  226. 04/26/2012 Case Study Presented on Achieving Biological Assay Success

  227. 04/16/2012 Catalent Expert Presents at German Pharma Congress

  228. 04/15/2012 Nascent and Catalent Sign Cancer Antibody Development Deal

  229. 04/11/2012 Two Global Catalent Experts Present at AAPS Workshop

  230. 04/10/2012 Catalent Expert To Share Formulation Development Expertise at Aerosol School

  231. 04/09/2012 Catalent Expert to Present at ISPE Japan 2012

  232. 04/03/2012 BASF and Catalent Join Forces to Solve Bioavailability Challenges

  233. 04/02/2012 Catalent Expert Presents Case Study at PDA

  234. 03/29/2012 Pharma Industry in NJ: A Panel Discussion

  235. 03/21/2012 Catalent Extends Development and Analytical Solutions Capabilities in UK

  236. 03/14/2012 Catalent Experts To Present Drug Delivery Technologies At ICSE/CPhI Japan 2012

  237. 03/11/2012 Catalent Appoints a Vice President of Commercial Excellence

  238. 03/07/2012 Expert Presents At The 5th Annual Comparator Studies Conference

  239. 03/06/2012 Catalent Continues Investment In Global Clinical Supply Services

  240. 03/01/2012 Drug Delivery Innovations Presented at 2nd Lyophilization Americas Conference

  241. 02/28/2012 Catalent Acquires 100% of R.P. Scherer - Eberbach, Germany

  242. 02/20/2012 Catalent Expert Presents on Protein Expression in CHO Cells

  243. 02/19/2012 Catalent Expert Presents Effective Global Supply Chain Solutions

  244. 02/16/2012 Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit

  245. 02/15/2012 Catalent and NewMarket Pharmaceuticals to Develop Better Treatments

  246. 01/31/2012 Expansion Advanced Dose Form Facility In Italy Complete

  247. 01/29/2012 Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

  248. 01/24/2012 Catalent Expands Controlled Release Drug Development & Supply

  249. 01/18/2012 Catalent Expert To Present On Virological Safety

  250. 01/17/2012 Catalent Expert To Present On Technology Delivery

  251. 01/15/2012 Catalent Expert to Present Strategies for Improved Oral Delivery

  252. 01/03/2012 Catalent Expert to Present at Peptalk 2012

  253. 12/06/2011 Catalent Plans to Increase Biologic Development and Manufacturing Capabilities

  254. 11/30/2011 Catalent Expert to Present Strategies to Support Intelligent Global Sourcing

  255. 11/08/2011 New Vice President and General Manager of Sterile Technologies Appointed

  256. 11/02/2011 Catalent Expert To Discuss The Effect of Immunoglobulin

  257. 11/01/2011 Catalent Joins Inhalation Experts to Advance Industry Science

  258. 10/19/2011 Catalent Focus On Expansion and New Technologies at ICSE/CPhI

  259. 10/16/2011 Catalent Highlight New Drug Delivery Technologies and Scientific Expert Events

  260. 10/05/2011 Catalent Expands Analytical Services Capabilities With A New Lab in Swindon, UK

  261. 09/27/2011 Catalent Expert to Present A Case Study of A Phase III Trial

  262. 09/26/2011 Expert to Present Technology Solutions for Biologics Challenges

  263. 09/25/2011 Catalent Expert Presents On Practical Considerations for Bioassays

  264. 09/22/2011 Catalent to Present Webinar on Applied Drug Delivery

  265. 09/20/2011 New VP Business Development, Zydis® Technology, Appointed

  266. 09/20/2011 Catalent and Toyobo Team Up To Launch GPEx®

  267. 09/19/2011 Catalent Announces Partnership With Toyobo Biologics, Inc.

  268. 09/13/2011 Catalent Expansions Show Close Pharma-Biz Tracking

  269. 09/12/2011 Catalent Announces Expansion of Its Advanced Dose Form Facility in Italy

  270. 09/11/2011 Expert to Present at 4th Annual Drug Repositioning Conference

  271. 09/07/2011 Catalent Expert Presents On Viral Safety

  272. 08/21/2011 Catalent to Acquire Aptuit LLC's Clinical Trial Supplies Business

  273. 08/14/2011 Catalent Expert Elsevier Webinar on Biosimiliars and Biobetters

  274. 08/07/2011 Catalent Expert Presents at 3rd Annual FDA Supplier Quality Management Congress

  275. 08/02/2011 Catalent Announces Cold-Chain Expansions to Meet Increasing Customer Demand

  276. 07/27/2011 Catalent Expert Presents New Technologies at 38th Annual CRS Conference

  277. 07/13/2011 Novel OSDrC® Optimized Dosing Technology Introduced

  278. 07/04/2011 Catalent Expert To Present Webinar On Biosimilars and Biobetters

  279. 06/29/2011 Catalent Invests In Global Clinical Suppy Services Capacity and Offering

  280. 06/28/2011 New Medication Delivery Solutions President Appointed

  281. 06/22/2011 Catalent Experts Present at HBA Global Expo 2011

  282. 06/22/2011 Catalent Presents At 7th Annual Improving Solubility Summit

  283. 06/15/2011 CEVEC and Catalent Offer Joint Cell Line Development Service

  284. 06/10/2011 Drug Delivery Trends and Topics With Catalent VP of Strategy

  285. 05/16/2011 Catalent’s Patient Adherence Packaging Design Honored

  286. 05/08/2011 Catalent Expert Presents the Requirements and Importance of Viral Safety

  287. 05/03/2011 New Vice President of Scientific Affairs Appointed

  288. 05/01/2011 Study Shows Adherence Packaging Solutions Drives Gains in Patient Persistency

  289. 04/13/2011 Catalent Announces New Sales Leadership Appoinments

  290. 03/22/2011 Catalent Presents at the 5th Annual Improving Solubility Conference

  291. 03/20/2011 Catalent to Present at INTERPHEX 2011

  292. 03/17/2011 Catalent Appoints New Vice President/General Manager of Consumer Health Softgel

  293. 03/13/2011 Catalent Pharma Solutions Appoints New Senior Vice President of Human Resources

  294. 03/09/2011 Catalent's Schorndorf Facility Celebrates 50 Years

  295. 03/08/2011 Catalent Expert to Teach Drug Development at Institute

  296. 03/08/2011 Catalent Expert Speaks on the Future of Biologics

  297. 02/27/2011 Catalent agrees to sell Printed Components business

  298. 02/16/2011 Catalent Experts Featured At PQRI Workshop

  299. 02/14/2011 Catalent Acquires Exclusive Rights to Lyopan® Fast-Dissolve Technology

  300. 02/02/2011 Catalent to present Efficient Solid-State Screening Using FT-Raman Spectroscopy

  301. 01/30/2011 Catalent Announces Partnership with Nuron Biotech for Phase III Clinical Study

  302. 01/23/2011 Catalent Expert to Present Drug Delivery Solutions to Enhance Bioavailability

  303. 01/18/2011 Catalent Experts to Present Webinar on Fit-For-Purpose Strategies for Solid-Form

  304. 01/16/2011 Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing...

  305. 01/13/2011 Catalent Expert Delivers US Pharmacopeia Update at 10th Annual Europe Conference

  306. 01/09/2011 Catalent Appoints New Leadership Talent in Global Manufacturing Sites

  307. 01/04/2011 Catalent Clinical Supply Continues to Invest in Automation to Drive High ...

  308. 12/20/2010 Microbiology and Sterility in Pharmaceuticals and Medical Devices

  309. 12/09/2010 Lean Pharma Product Development

  310. 12/08/2010 Catalent Strengthens and Expands

  311. 12/07/2010 Catalent Scientists to Chair

  312. 12/01/2010 Catalent Vice President Shares

  313. 11/10/2010 Catalent Expert to Present

  314. 11/03/2010 Catalent Provides a Simplified

  315. 11/01/2010 Nine Catalent Experts to Present

  316. 10/27/2010 Senior Director of Biotechnology

  317. 10/26/2010 Catalent Appoints New Global

  318. 10/25/2010 Catalent Receives Award

  319. 10/12/2010 Catalent's Eberbach, Germany Site

  320. 10/10/2010 Catalent Expert Leads Workshop

  321. 10/03/2010 Catalent R&D Director Appointed

  322. 09/13/2010 Catalent to Present Ground-Breaking

  323. 09/08/2010 Catalent Softgel Expert to Present

  324. 08/23/2010 Catalent Provides Sunesis

  325. 08/23/2010 Catalent Pharma Solutions Provides Manufacturing and Packaging Expertise

  326. 08/08/2010 World-Class Optiform™ Compound

  327. 07/25/2010 Catalent Scientists to Present

  328. 07/22/2010 Catalent Principal Scientists

  329. 07/20/2010 Catalent Pharma Solutions Adds Pharma

  330. 07/14/2010 Catalent Expert Appointed as Chair

  331. 06/27/2010 Catalent Expert Appointed

  332. 06/27/2010 Catalent Director of Research

  333. 06/21/2010 TraceLink and Catalent Deliver

  334. 06/15/2010 Catalent Joins Business Ethics

  335. 06/13/2010 Senior Director of Biotechnology

  336. 06/10/2010 Catalent Pharma Solutions

  337. 06/09/2010 Catalent Expert Presenting

  338. 06/09/2010 Catalent to Exhibit

  339. 05/10/2010 Catalent Scientists to Present

  340. 05/10/2010 Catalent Announces Lead

  341. 05/09/2010 Catalent Appoints New Vice President

  342. 05/02/2010 Catalent Pharma Solutions

  343. 03/24/2010 Catalent Formulation Expert

  344. 03/22/2010 Catalent Appoints Two

  345. 03/10/2010 Catalent to Present Webinar

  346. 02/17/2010 Catalent Scientist to Co-Chair

  347. 02/10/2010 Catalent Scientist to Present at 2010

  348. 02/01/2010 Catalent Pharma Solutions Appoints

  349. 01/31/2010 Catalent Adds Potent Drug

  350. 01/13/2010 Catalent Expands Packaging Capacity

  351. 01/10/2010 Catalent Solidifies Inhalation

  352. 11/23/2009 Catalent Appoints New Vice President of Global Sales

  353. 11/15/2009 Catalent's Printed Components Plant in Dublin is the First Secondary

  354. 11/04/2009 Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma

  355. 11/03/2009 Catalent Expands Capabilities in Testing for Melamine in Food

  356. 11/02/2009 FDA Approves New Salix Product Exclusively in Catalent's Zydis®

  357. 11/02/2009 Catalent to Present at American Association of Pharmaceutical Scientists Meeting

  358. 10/22/2009 Catalent Develops New Decorin Molecule Form, Strikes Deal With Euclid

  359. 10/19/2009 Catalent Wins Outsourcing Award

  360. 10/18/2009 Catalent Offers the Anti-Counterfeiting DigiTrack™ Digital Watermarking System

  361. 10/06/2009 Catalent Pharma Solutions German Facility Successfully Completes FDA Audit

  362. 10/05/2009 Catalent Pharma Solutions' United Kingdom Packaging Site Receives High

  363. 09/27/2009 Catalent Pharma Solutions Appoints New Sterile Segment President

  364. 09/23/2009 Catalent and GlaxoSmithKline Extend Contractual Agreement

  365. 08/30/2009 Catalent's New Digital Offset Press Reduces Lead Times for Printed Components

  366. 08/19/2009 Catalent Pharma Solutions Creates New Development & Clinical Services Segment

  367. 08/18/2009 Catalent Pharma Solutions Buenos Aires Facility Successfully Completes First FDA Audit

  368. 08/12/2009 Catalent Receives "Preferred Partner Award in Technology" from Wyeth

  369. 06/24/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  370. 05/31/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  371. 05/04/2009 Catalent Pharma Solutions Supports Global Industry Response

  372. 04/30/2009 Catalent Brings Innovative Printing Technology

  373. 04/08/2009 Catalent Pharma Solutions Celebrates 75 Years of Softgel Innovation in 2009

  374. 03/30/2009 BAVARIA Industriekapital AG Announces Acquisition of Osny

  375. 03/17/2009 Catalent Pharma Solutions Announces Printed Components

  376. 03/04/2009 Catalent Pharma Solutions Appoints New President and Chief Executive Officer